94 related articles for article (PubMed ID: 8608876)
1. Better survival rates in patients with MLH1-associated hereditary colorectal cancer.
Sankila R; Aaltonen LA; Järvinen HJ; Mecklin JP
Gastroenterology; 1996 Mar; 110(3):682-7. PubMed ID: 8608876
[TBL] [Abstract][Full Text] [Related]
2. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients.
Stigliano V; Assisi D; Cosimelli M; Palmirotta R; Giannarelli D; Mottolese M; Mete LS; Mancini R; Casale V
J Exp Clin Cancer Res; 2008 Sep; 27(1):39. PubMed ID: 18803843
[TBL] [Abstract][Full Text] [Related]
3. Early-Onset Colon Cancer: A Narrative Review of Its Pathogenesis, Clinical Presentation, Treatment, and Prognosis.
Lingas EC
Cureus; 2023 Sep; 15(9):e45404. PubMed ID: 37854763
[TBL] [Abstract][Full Text] [Related]
4. Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice.
Ascrizzi S; Arillotta GM; Grillone K; Caridà G; Signorelli S; Ali A; Romeo C; Tassone P; Tagliaferri P
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568746
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability-Lessons from Colorectal Cancer.
Greco L; Rubbino F; Dal Buono A; Laghi L
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372349
[TBL] [Abstract][Full Text] [Related]
6. Early-onset colorectal cancer: A review of current knowledge.
Saraiva MR; Rosa I; Claro I
World J Gastroenterol; 2023 Feb; 29(8):1289-1303. PubMed ID: 36925459
[TBL] [Abstract][Full Text] [Related]
7. Defects in MMR Genes as a Seminal Example of Personalized Medicine: From Diagnosis to Therapy.
Dal Buono A; Gaiani F; Poliani L; Correale C; Laghi L
J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945805
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 Expression Is Significantly Associated with Tumor Mutation Burden and Microsatellite Instability Score.
Cho YA; Lee H; Kim DG; Kim H; Ha SY; Choi YL; Jang KT; Kim KM
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572886
[TBL] [Abstract][Full Text] [Related]
9. Comparison of oncologic outcomes between patients with Lynch syndrome and sporadic microsatellite instability-high colorectal cancer.
Son IT; Kim DW; Kim MH; Shin YK; Ku JL; Oh HK; Kang SB; Jeong SY; Park KJ
Ann Surg Treat Res; 2021 Jul; 101(1):13-19. PubMed ID: 34235112
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes.
Gaiani F; Marchesi F; Negri F; Greco L; Malesci A; de'Angelis GL; Laghi L
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34063506
[TBL] [Abstract][Full Text] [Related]
11. Cross-platform Data Analysis Reveals a Generic Gene Expression Signature for Microsatellite Instability in Colorectal Cancer.
Pačínková A; Popovici V
Biomed Res Int; 2019; 2019():6763596. PubMed ID: 31008109
[TBL] [Abstract][Full Text] [Related]
12. Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients.
Brungs D; Aghmesheh M; de Souza P; Ng W; Chua W; Carolan M; Clingan P; Healey E; Rose J; Tubaro T; Ranson M
BMC Cancer; 2017 Apr; 17(1):251. PubMed ID: 28390415
[TBL] [Abstract][Full Text] [Related]
13. Approach to Lynch Syndrome for the Gastroenterologist.
Bui QM; Lin D; Ho W
Dig Dis Sci; 2017 Feb; 62(2):299-304. PubMed ID: 27990589
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.
Win AK; Jenkins MA; Dowty JG; Antoniou AC; Lee A; Giles GG; Buchanan DD; Clendenning M; Rosty C; Ahnen DJ; Thibodeau SN; Casey G; Gallinger S; Le Marchand L; Haile RW; Potter JD; Zheng Y; Lindor NM; Newcomb PA; Hopper JL; MacInnis RJ
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):404-412. PubMed ID: 27799157
[No Abstract] [Full Text] [Related]
15. Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.
McMeekin DS; Tritchler DL; Cohn DE; Mutch DG; Lankes HA; Geller MA; Powell MA; Backes FJ; Landrum LM; Zaino R; Broaddus RD; Ramirez N; Gao F; Ali S; Darcy KM; Pearl ML; DiSilvestro PA; Lele SB; Goodfellow PJ
J Clin Oncol; 2016 Sep; 34(25):3062-8. PubMed ID: 27325856
[TBL] [Abstract][Full Text] [Related]
16. Opportunities for immunotherapy in microsatellite instable colorectal cancer.
Westdorp H; Fennemann FL; Weren RD; Bisseling TM; Ligtenberg MJ; Figdor CG; Schreibelt G; Hoogerbrugge N; Wimmers F; de Vries IJ
Cancer Immunol Immunother; 2016 Oct; 65(10):1249-59. PubMed ID: 27060000
[TBL] [Abstract][Full Text] [Related]
17. Human mutL homolog 1 expression characteristic and prognostic effect on patients with sporadic colorectal cancer.
Pu C; Ren W; Sun Z; Yu X; Yuan W; Huang M; Shen S; Wang X
Int J Clin Exp Med; 2015; 8(10):19652-61. PubMed ID: 26770629
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?
Maccaroni E; Bracci R; Giampieri R; Bianchi F; Belvederesi L; Brugiati C; Pagliaretta S; Del Prete M; Scartozzi M; Cascinu S
Oncotarget; 2015 Nov; 6(36):38737-48. PubMed ID: 26485756
[TBL] [Abstract][Full Text] [Related]
19. Hereditary ovarian cancer: not only BRCA 1 and 2 genes.
Toss A; Tomasello C; Razzaboni E; Contu G; Grandi G; Cagnacci A; Schilder RJ; Cortesi L
Biomed Res Int; 2015; 2015():341723. PubMed ID: 26075229
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of mismatch repair gene expression in sporadic colorectal cancer.
Sun Z; Yu X; Wang H; Zhang S; Zhao Z; Xu R
Exp Ther Med; 2014 Nov; 8(5):1416-1422. PubMed ID: 25289032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
